Julian S. Gangolli
Director · Krystal Biotech, Inc.
Individual
- 2024
- Sep 17, 2026
- 3
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Julian S. Gangolli files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Suma Krishnan - $34.27M in KRYS purchases and sales in the last 12 months
- Krish S. Krishnan - $34.27M in KRYS purchases and sales in the last 12 months
- Daniel Janney - $19.40M in KRYS purchases and sales in the last 12 months
- Dino A. Rossi - $13.18M in KRYS purchases and sales in the last 12 months
- Kathryn Romano - $3.60M in KRYS purchases and sales in the last 12 months
- John Charles Thomas - $541K in KRYS purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Julian S. Gangolli?
Julian S. Gangolli is a corporate insider, tracked as Director of Krystal Biotech, Inc. (KRYS). InsiderAlpha holds 3 primary Form 4 filings for them, the earliest from 2024, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has Julian S. Gangolli submitted recently?
1 primary Form 4 filing in the last 90 days, covering 1 company.
